Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-08-21
1988-05-17
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514332, 514333, 514336, 514341, 546256, 546263, 546266, 546278, 546283, 546284, 546339, 546340, 546342, 546344, A61K 3144, A61K 31455, C07D21350, C07D40112
Patent
active
047451203
ABSTRACT:
The present invention relates to new pyridines substituted in the 3-position, of the formula ##STR1## and to a process for their preparation. The compounds bring about specific inhibition of thromboxane synthetase and can thus be used as medicaments.
REFERENCES:
patent: 4271176 (1981-06-01), Tanouchi et al.
patent: 4317828 (1982-03-01), Tanouchi et al.
patent: 4427680 (1984-01-01), Tanouchi et al.
Glossary of Chemical Terms, Hampel and Hawley, Editors, p. 6.
Tanouchi et al., Highly Selective . . . Pyridine Derivatives, J. Med. Chem., 1981, 24, 1149-1155.
Bartmann Wilhelm
Beck Gerhard
Lau Hans-Hermann
Wess Gunther
Bjorkman Dale A.
Hoechst Aktiengesellschaft
Jiles Henry R.
LandOfFree
3-pyridyl compounds and use as thromboxane synthetase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-pyridyl compounds and use as thromboxane synthetase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-pyridyl compounds and use as thromboxane synthetase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1881620